William L. Isley

2.8k total citations
51 papers, 1.8k citations indexed

About

William L. Isley is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, William L. Isley has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in William L. Isley's work include Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Lipoproteins and Cardiovascular Health (11 papers) and Diabetes Management and Research (11 papers). William L. Isley is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Lipoproteins and Cardiovascular Health (11 papers) and Diabetes Management and Research (11 papers). William L. Isley collaborates with scholars based in United States, Italy and South Korea. William L. Isley's co-authors include William S. Harris, David R. Clemmons, Mikhail Kosiborod, Antonio Ceriello, Theodore Mazzone, Prakash Deedwania, Eugene J. Barrett, Philip Raskin, Louis E. Underwood and John J. Miles and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Annals of Internal Medicine.

In The Last Decade

William L. Isley

51 papers receiving 1.6k citations

Peers

William L. Isley

EDM

CCM

SURGE

PHYSI

Maria Luiza Caramori United States

Ilaria Ferrari Italy

R. S. Elkeles United Kingdom

Remco Franssen Netherlands

Donatella Siepi Italy

Moshe Weintraub Israel

Akintunde O. Akinkuolie United States

Itamar Grosskopf Israel

Tiina Solakivi Finland

A.H.M. Smelt Netherlands

Maria Luiza Caramori United States

William L. Isley

852 ×0.8

EDM

395 ×0.9

CCM

368 ×1.0

SURGE

555 ×1.5

264 ×1.0

PHYSI

Citations per year, relative to William L. Isley William L. Isley (= 1×) peers Maria Luiza Caramori

Countries citing papers authored by William L. Isley

Since Specialization

Citations

This map shows the geographic impact of William L. Isley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William L. Isley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William L. Isley more than expected).

Fields of papers citing papers by William L. Isley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William L. Isley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William L. Isley. The network helps show where William L. Isley may publish in the future.

Co-authorship network of co-authors of William L. Isley

This figure shows the co-authorship network connecting the top 25 collaborators of William L. Isley. A scholar is included among the top collaborators of William L. Isley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William L. Isley. William L. Isley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deedwania, Prakash, Mikhail Kosiborod, Eugene J. Barrett, et al.. (2008). Hyperglycemia and Acute Coronary Syndrome. Circulation. 117(12). 1610–1619. 371 indexed citations

Snozek, Christine L.H., Susan A. Lagerstedt, Teck Kim Khoo, et al.. (2008). LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance. European Journal of Human Genetics. 17(1). 85–90. 12 indexed citations

Isley, William L., John J. Miles, & William S. Harris. (2007). Pilot study of combined therapy with ω-3 fatty acids and niacin in atherogenic dyslipidemia. Journal of clinical lipidology. 1(3). 211–217. 7 indexed citations

Kudva, Yogish C., Ananda Basu, Gregory D. Jenkins, et al.. (2007). Glycemic Variation and Hypoglycemia in Patients with well-Controlled Type 1 Diabetes on a Multiple Daily Insulin Injection Program with use of Glargine and Ultralente as Basal Insulin. Endocrine Practice. 13(3). 244–250. 16 indexed citations

Montori, Víctor M., William L. Isley, & Gordon Guyatt. (2007). Waking up from the DREAM of preventing diabetes with drugs. BMJ. 334(7599). 882–884. 27 indexed citations

Magee, Michelle & William L. Isley. (2006). Rationale, Design, and Methods for Glycemic Control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. The American Journal of Cardiology. 97(12). 20–30. 39 indexed citations

Isley, William L., William S. Harris, & John J. Miles. (2006). The effect of high-dose simvastatin on free fatty acid metabolism in patients with type 2 diabetes mellitus. Metabolism. 55(6). 758–762. 22 indexed citations

Sierra‐Johnson, Justo, Virend K. Somers, Fatima H. Sert Kuniyoshi, et al.. (2006). Comparison of Apolipoprotein-B/Apolipoprotein-AI in Subjects With Versus Without the Metabolic Syndrome. The American Journal of Cardiology. 98(10). 1369–1373. 72 indexed citations

Isley, William L., Yongsoon Park, & William S. Harris. (2006). The effect of high dose simvastatin on, platelet size in patients with, type 2 diabetes mellitus. Platelets. 17(5). 292–295. 2 indexed citations

10.

Isley, William L.. (2006). Low-density lipoprotein cholesterol lowering in the prevention of CHD: How low should we go?. Current Treatment Options in Cardiovascular Medicine. 8(4). 289–297. 7 indexed citations

11.

Yue, Pin, et al.. (2004). Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in FHBL. Atherosclerosis. 178(1). 107–113. 20 indexed citations

12.

Harris, William S., Yongsoon Park, & William L. Isley. (2003). Cardiovascular disease and long-chain omega-3 fatty acids. Current Opinion in Lipidology. 14(1). 9–14. 66 indexed citations

13.

Yue, Pin, Bo Yuan, Daniela S. Gerhard, et al.. (2002). Novel mutations ofAPOB cause ApoB truncations undetectable in plasma and familial hypobetalipoproteinemia. Human Mutation. 20(2). 110–116. 15 indexed citations

14.

Isley, William L., et al.. (2001). Hepatotoxicity of thiazolidinediones. Diabetes Obesity and Metabolism. 3(6). 389–392. 19 indexed citations

15.

Isley, William L., et al.. (1997). Rhabdomyolysis Associated With Simvastatin–Gemfibrozil Therapy. Southern Medical Journal. 90(5). 546–547. 53 indexed citations

16.

Reasner, Charles A. & William L. Isley. (1997). Endocrine emergencies. Postgraduate Medicine. 101(3). 231–242. 5 indexed citations

17.

Isley, William L., et al.. (1997). Estrogen-induced pancreatitis after discontinuation of concomitant medroxyprogesterone therapy. The American Journal of Medicine. 102(4). 416–417. 12 indexed citations

18.

Parker, Robert, John W. Rapley, William L. Isley, Paulette Spencer, & William J. Killoy. (1993). Gingival Crevicular Blood for Assessment of Blood Glucose in Diabetic Patients. Journal of Periodontology. 64(7). 666–672. 50 indexed citations

19.

Isley, William L., Stephen L. Dahl, & Harry Gibbs. (1990). Use of esmolol in managing a thyrotoxic patient needing emergency surgery. The American Journal of Medicine. 89(1). 122–123. 27 indexed citations

20.

Isley, William L., et al.. (1989). Unilateral Adrenal Hyperplasia as a Cause of Primary Aldosteronism. Southern Medical Journal. 82(1). 82–86. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact